Forced expression of RDH10 gene retards growth of HepG2 cells.
Rossi E
Cancer Biol Ther. 2007 Feb 25;6(2):238-44.
Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice and nonhuman primates.
Carlo-Stella C
Stem Cells. 2006 Sep 28;25(1):252-61.
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.
Carlo-Stella C
Hum Gene Ther. 17(12):1225-40.
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice.
Carlo-Stella C
Exp Hematol. 34(6):721-7.
Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.
Matteucci P
Haematologica. 91(2):255-7.
The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.
Carlo-Stella C
Cancer Res. 66(3):1799-808.
Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with gammac cytokines.
Anichini A
Blood. 2005 Sep 8;107(2):602-9.
Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed.
Dodero A
Exp Hematol. 33(8):920-7.
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.
Ricca I
Leukemia. 19(4):644-51.
High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt’s lymphoma in adults.
Di Nicola M
Br J Haematol. 126(6):815-20.